Skip to content

Characterizing Hemorrhage in Acute Spinal Cord Injury With MRI

Characterizing Hemorrhage in Acute Spinal Cord Injury With MRI

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04758377
Acronym
CHASM
Enrollment
24
Registered
2021-02-17
Start date
2021-02-06
Completion date
2025-06-01
Last updated
2023-07-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Traumatic Spinal Cord Haemorrhage

Keywords

vasopressors, magnetic resonance imaging

Brief summary

The study is designed to determine whether hemorrhage within the injured spinal cord is influenced by mean arterial pressure (MAP) augmentation with vasopressors and by venous thromboembolism (VTE) prophylaxis with anticoagulants in the first two weeks following a traumatic spinal cord injury (tSCI).

Detailed description

This will be a single-center prospective observational study of patients with an acute cervical traumatic spinal cord injury

Interventions

PROCEDUREMagnetic resonance imaging (MRI)

Serial MRI scans of patients with acute cervical SCI to quantify hemorrhage.

Sponsors

United States Department of Defense
CollaboratorFED
University of British Columbia
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
19 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Acute tSCI injury involving bony spinal levels between C0 and T1 * Baseline Asia Impairment Scale (AIS) grade of A, B, or C * Admission to study site within 24 hours of injury * Male or female age 19 or older * Able and willing to provide informed consent

Exclusion criteria

* Pathological fracture due to metabolic condition or neoplasia * Spinal cord injury due to infection * Presence of pacemaker, aneurysm clip or other device which is a contraindication to MRI * BMI \> 40 and unable to fit within the MRI scanner * Multiple life threatening injuries (ISS \>16) that make transport to MRI not in the patient's best interest * Any condition that, at the time of admission, prevents a complete ISNCSCI assessment from being performed

Design outcomes

Primary

MeasureTime frameDescription
Hemorrhage Quantification 1Serial MRI assessments: Injury to 2 weeks post injuryArea of hematoma
Hemorrhage Quantification 2Serial MRI assessments: Injury to 2 weeks post injuryVertical length of hematoma and vertical length of cord edema
Hemorrhage Quantification 3Serial MRI assessments: Injury to 2 weeks post injuryThe point of maximum cord compression vertebral level and anatomic point of maximum cord compression vertebral sublevel
Hemorrhage Quantification 4Serial MRI assessments: Injury to 2 weeks post injuryVertical length of cord edema rostral to maximum compression and vertical length of cord edema caudal to maximum compression.

Secondary

MeasureTime frameDescription
Hemodynamic Management Assessment 1Injury to 2 weeks post injuryachieved mean arterial pressure
Hemodynamic Management Assessment 2Injury to 2 weeks post injuryvasopressor usage/dose

Other

MeasureTime frameDescription
Neurologic AssessmentsInjury to 6 months post injuryInternational Standards for Neurological Classification of SCI (ISNCSCI)

Countries

Canada

Contacts

Primary ContactAllan Aludino
allan.aludino@vch.ca604-875-4111

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026